MODULATION BY ANGIOTENSIN-II OF ISOPROTERENOL-INDUCED CAMP PRODUCTIONIN PREGLOMERULAR MICROVASCULAR SMOOTH-MUSCLE CELLS FROM NORMOTENSIVE AND GENETICALLY HYPERTENSIVE RATS
R. Mokkapatti et al., MODULATION BY ANGIOTENSIN-II OF ISOPROTERENOL-INDUCED CAMP PRODUCTIONIN PREGLOMERULAR MICROVASCULAR SMOOTH-MUSCLE CELLS FROM NORMOTENSIVE AND GENETICALLY HYPERTENSIVE RATS, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 223-231
The objectives of the present study were to determine whether angioten
sin II (Ang II) modifies beta-adrenoceptor-induced cAMP production in
preglomerular microvascular smooth muscle cells (PMVSMCs), to determin
e whether the Ang II/beta-adrenoceptor interaction on cAMP production
differs in PMVSMCs from normotensive Wistar-Kyoto (WKY) rats vs. PMVSM
Cs from spontaneously hypertensive rats (SHR), and to elucidate the me
chanism of Ang II/beta-adrenoceptor interactions on cAMP production in
PMVSMCs. In cultured PMVSMCs, isoproterenol increased cAMP levels and
this effect was markedly enhanced by Ang II. The Ang II enhancement o
f isoproterenol-induced cAMP was significantly greater in SHR PMVSMCs
compared with WKY PMVSMCs. Neither inhibition of calcineurin with FK50
6, inhibition of calcium-calmodulin with W-7 and calmidazolium, nor in
hibition of Gi proteins with pertussis toxin attenuated Ang II enhance
ment of isoproterenol-induced cAMP in PMVSMCs from either SHR or WKY r
ats. Moreover, the effect of Ang II on isoproterenol-induced cAMP was
not mimicked by alpha-2 adrenoceptor stimulation. in contrast, chelati
on of intracellular calcium with BAPTA-AM attenuated, increasing intra
cellular calcium with A23187 augmented, and inhibition of protein kina
se C with either calphostin C or chelerythrine chloride abolished Ang
II enhancement of isoproterenol-induced cAMP. We conclude that in cult
ured PMVSMCs Ang II enhances the cAMP response to beta-adrenoceptor ag
onists via a mechanism that involves coincident activation of adenylyl
cyclase by stimulatory G proteins and protein kinase C. Thus, protein
kinase C-mediated activation of adenylyl cyclase may attenuate Ang II
-induced vasoconstriction in the renal microcirculation by raising the
intracellular levels of cAMP, and this mechanism may be augmented in
genetic hypertension.